Donate

Your Help Makes Our Mission Possible

Together, we can change an unfair status quo by giving women and girls across the globe greater control of their fertility, their health, and their lives.

The global unmet need for innovation in women’s health is vast and the stakes are high. When you support Medicines360, you give women more control over their health and greater reproductive autonomy. Make your tax-deductible contribution today.

Three Reasons to Support Medicines360

Help expand our global footprint.

Serving more women in more countries requires working on a country-by-country basis with government officials, identifying on-the-ground distribution partners, and training new providers.

Help keep new innovations affordable.

Co-funding from our supporters like you allows our products to be offered at an affordable price, which expands access for women in Kenya, Madagascar, Nigeria, Rwanda, Tanzania, Uganda, and Zambia – with additional countries coming soon.

Help advance our nonprofit pharma mission.

Developing new and innovative products can help close the access gap to make sure all women have access to the medicines they need — regardless of location or socio-economic status.

DAF: Donor-Advised Fund Contributions

Consider growing your investment in our mission with a contribution from your donor-advised fund (DAF).

Recommend a donation through your DAF.

Please make checks payable to:

Medicines360
EIN: 26-4443340
49 Stevenson Street, Suite 1100
San Francisco, CA 94105 

In order to acknowledge your generous gift, please provide your name and/or fund name and address.

For those who wish to electronically transfer funds to Medicines360, gifts may be sent via wire transfer. Please follow the instructions here, or reach out to Lynsey Chediak at lkchediak@medicines360.org if additional support is needed.

Consider growing your investment in our mission with a contribution from your donor-advised fund (DAF).

Stay Informed

Sign up for our quarterly e-newsletter focused on improving women’s health.

Medicines360 respects individual privacy and values the confidence of our customers. By submitting the information above, you understand this information will be used in accordance with our Privacy Policy. You further acknowledge that Medicines360 and its business partners may send you relevant information regarding disease education, as well as information on related products or services, and for marketing or other informational purposes. You may opt out of receiving such communications by unsubscribing directly from emails sent to you or sending an email request to the address below. Your choices regarding our use and disclosure of your Personal Information:

We give you many choices regarding our use and disclosure of your Personal Information for marketing purposes.  You may opt out from: 

  • Receiving marketing-related emails from us:  If you no longer want to receive marketing-related emails from us on a going-forward basis, you may opt out of receiving these marketing-related emails by following the instructions included in email communications from us, or contact us at: access@medicines360.org.
  • Our sharing of your Personal Information with affiliates for their marketing purposes:  If you would prefer that we do not share your Personal Information on a going-forward basis with our affiliates for their marketing purposes, you may opt out of this sharing by notifying us sending us a written statement to: Medicines360 Website, 49 Stevenson St | Suite 1100 | San Francisco, CA 94105  USA,  by following the instructions included in email communication you received  from us, or by contacting us at: access@medicines360.org.
  1. Kaiser Family Foundation. Women’s Health Insurance Coverage. Accessed June 2022
  2. The Lancet. Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970–2019: a systematic analysis for the Global Burden of Disease Study 2019. Accessed August 2022
  3. Sully EA et al., Adding It Up: Investing in Sexual and Reproductive Health 2019, New York: Guttmacher Institute, 2020, https://www.guttmacher.org/fact-sheet/investing-sexual-and-reproductive-health-low-and-middle-income-countries
  4. AVIBELA is not available in the United States. In the US, our hormonal IUD is marketed under the name LILETTA®.